Literature DB >> 21671781

Inverse association between total bilirubin and metabolic syndrome in rural korean women.

Kyung-Min Kwon1, Jin-Hwa Kam, Min-Young Kim, Moon-Young Kim, Choon Hee Chung, Jong-Koo Kim, John A Linton, Aeyong Eom, Sang-Baek Koh, Hee-Taik Kang.   

Abstract

UNLABELLED: Abstract Background: Chronic inflammation and oxidative stress are associated with the development of metabolic syndrome (MetS). Bilirubin is an antioxidant and has a protective effect against cardiovascular disease (CVD). The purpose of this study was to examine the association between total bilirubin levels and the prevalence of MetS in rural Korean women.
METHODS: This cross-sectional study included 5,266 women (>40 years) enrolled in the Korean Genomic Rural Cohort (KGRC). MetS was defined using the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) guidelines. Total bilirubin levels were categorized into quartiles.
RESULTS: Subjects in the upper quartiles of total bilirubin were younger and had lower waist circumferences, systolic blood pressure, and triglyceride levels and higher high-density lipoprotein cholesterol (HDL-C) concentrations. The overall prevalence of MetS was 39.0%. When the participants were categorized into quartiles by total bilirubin level, the prevalence of MetS according to increasing total bilirubin quartiles was 47.9%, 41.2%, 34.3%, and 32.7%, respectively. By comparison to the lowest quartile of total bilirubin (<0.61 mg/dL), the odds ratio (OR) (95% confidence interval [CI]) for MetS in the highest quartile of total bilirubin (≥0.94 mg/dL) was 0.63 (0.52-0.77) after adjusting for menopausal status, C-reactive protein (CRP) levels, insulin resistance, and other covariates.
CONCLUSIONS: Total bilirubin level appears to be inversely associated with the prevalence of MetS in rural Korean women >40 years of age in the KGRC, even after adjusting for risk factors of MetS, including body mass index (BMI), menopausal status, CRP levels, and homeostasis model assessment of insulin resistance (HOMA-IR).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671781     DOI: 10.1089/jwh.2010.2453

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  15 in total

Review 1.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

2.  Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.

Authors:  Darren M Gordon; Kari L Neifer; Abdul-Rizaq Ali Hamoud; Charles F Hawk; Andrea L Nestor-Kalinoski; Scott A Miruzzi; Michael P Morran; Samuel O Adeosun; Jeffrey G Sarver; Paul W Erhardt; Robert E McCullumsmith; David E Stec; Terry D Hinds
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

Review 3.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

Review 4.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

5.  The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases.

Authors:  Libor Vítek
Journal:  Front Pharmacol       Date:  2012-04-03       Impact factor: 5.810

6.  Bile pigments in pulmonary and vascular disease.

Authors:  Stefan W Ryter
Journal:  Front Pharmacol       Date:  2012-03-08       Impact factor: 5.810

7.  Effect of bilirubin on triglyceride synthesis in streptozotocin-induced diabetic nephropathy.

Authors:  Jianwei Xu; Eun Seong Lee; Seon Ha Baek; Shin-Young Ahn; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Ho Jun Chin
Journal:  J Korean Med Sci       Date:  2014-09-30       Impact factor: 2.153

8.  Serum bilirubin concentration is modified by UGT1A1 haplotypes and influences risk of type-2 diabetes in the Norfolk Island genetic isolate.

Authors:  M C Benton; R A Lea; D Macartney-Coxson; C Bellis; M A Carless; J E Curran; M Hanna; D Eccles; G K Chambers; J Blangero; L R Griffiths
Journal:  BMC Genet       Date:  2015-12-02       Impact factor: 2.797

9.  Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profiling.

Authors:  T Pallister; M A Jackson; T C Martin; C A Glastonbury; A Jennings; M Beaumont; R P Mohney; K S Small; A MacGregor; C J Steves; A Cassidy; T D Spector; C Menni; A M Valdes
Journal:  Int J Obes (Lond)       Date:  2017-03-15       Impact factor: 5.095

10.  Relationship between Serum Bilirubin Levels and Metabolic Syndrome in Patients with Schizophrenia Spectrum Disorders.

Authors:  Filiz Karadag; Ceyhan Balci Sengul; Yasar Enli; Kamuran Karakulah; Huseyin Alacam; Bunyamin Kaptanoglu; Ozgur Kalkanci; Hasan Herken
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-05-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.